Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
66,041,596
-
Total 13F shares
-
17,514,972
-
Share change
-
-172,398
-
Total reported value
-
$31,525,823
-
Price per share
-
$1.80
-
Number of holders
-
65
-
Value change
-
-$913,711
-
Number of buys
-
25
-
Number of sells
-
32
Institutional Holders of Neuronetics, Inc. - Common Stock, par value $0.01 per share (STIM) as of Q2 2024
As of 30 Jun 2024,
Neuronetics, Inc. - Common Stock, par value $0.01 per share (STIM) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,514,972 shares.
The largest 10 holders included
Archon Capital Management LLC, CANNELL CAPITAL LLC, Kent Lake Capital LLC, VANGUARD GROUP INC, First Washington CORP, SILVERCREST ASSET MANAGEMENT GROUP LLC, Balyasny Asset Management L.P., First Eagle Investment Management, LLC, G2 Investment Partners Management LLC, and Millrace Asset Group, Inc..
This page lists
65
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.